Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*
Structure of HCMV IE-1 248-256 (HLA-A*24:02)
Logo for Infectious disease
Infectious disease

HCMV IE-1 248-256 (HLA-A*24:02) AYAQKIFKI

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP11117_1

Description

AYAQKIFKI is a linear peptidic epitope (epitope ID140986) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

TechData

Sequence: AYAQKIFKI
Gene: UL123
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Immediate early protein IE1
UniProt Id: P13202
Species: Human cytomegalovirus (Human herpesvirus 5)
Allele: HLA-A*24:02
Application: Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication: Infectious disease, Cancer, Neuroscience, Diabetes
Purity: 95% HPLC-MS

Documents

Material data sheet Safety data sheet Storage and handling of peptides Probing of membranes with HRP
Skip product gallery

More HCMV IE1 peptides

HCMV IE-1 199-207 (HLA-B*08:01)
HCMV IE-1 199-207 (HLA-B*08:01)
ELRRKMMYM is a linear peptidic epitope (epitope ID 13133) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivit, tested in Tcell assays and MHC ligand assays.

From €105.00*
Details
HCMV IE-1 199-207 mutant (HLA-B*08:01) 201K, 205I
HCMV IE-1 199-207 mutant (HLA-B*08:01) 201K, 205I
ELKRKMIYM is a linear peptidic epitope (epitope ID 13133) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in Tcell assays and MHC ligand assays.

From €105.00*
Details
HCMV IE-1 316-324 (HLA-A*02:01)
HCMV IE-1 316-324 (HLA-A*02:01)
Antigen Peptide IE 316–324 - HLA-A*02:01 (ILEETSVML) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
Details
HCMV IE-1 378-389 (HLA-B18)
HCMV IE-1 378-389 (HLA-B18)
HCMV IE-1 378-389 (HLA-B18) is a HLA-B18-restricted epitope (epitope ID 57178) of Immediate early protein IE1 (UniProt:P13202) from Human Cytomegalovirus/Human herpesvirus 5. It consist of the amino acid sequence SDEEEAIVAYTL (378-389).

From €106.60*
Details
HCMV IE-1 99-107 (HLA-A*03:01)
HCMV IE-1 99-107 (HLA-A*03:01)
Antigen Peptide IE 99–107 - HLA-A*03:01 (RIKEHMLKK) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
Details
HCMV IE1 162-173 (HLA-DRB1*0801)
HCMV IE1 162-173 (HLA-DRB1*0801)
The Human Cytomegalovirus (HCMV) Immediate early protein 1 (IE-1) Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays.

From €109.20*
Details
HCMV IE1 51-59 (HLA-B*08:01)
HCMV IE1 51-59 (HLA-B*08:01)
CMV IE1-derived peptide of ELNRKMIYM covering 51-59 and B*08:01 molecule is a linear peptidic epitope (epitope ID 240792) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus), tested in T cell assays and MHC ligand assays.

From €105.00*
Details
MCMV IE1
MCMV IE1
The nonamer YPHFMPTNL is an immunodominant T-cell epitope for presentation on H-2Ld MHC class I molecules. The peptide serves as a substrate for the 20S proteasome both with and without activation by 11S activator complexes. The degradation products may be separated by reverse-phase high performance liquid chromatography and subsequently identified by mass spectrometry. The nature and abundance of the fragments produced will depend upon the nature of the 20S proteasome being studied and the extent of its activation. This peptide is processed from the immediate early protein pp89 of mouse cytomegalovirus (CMV). It is presented to CD8+ T lymphocytes by the H-2 Ld molecule. Infection of mice with murine CMV leads to CD8 cell responses to this immunodominant epitope. This peptide was employed in vaccines development. YPHFMPTNL is a linear peptidic epitope (epitope ID75317) studied as part of Immediate-early protein 1 from Murid betaherpesvirus 1 (Murine cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €105.00*
Details
This website uses cookies to ensure the best experience possible. More information...